Hideki Chiba

Prof. Dr. Hideki Chiba

Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Molecular Biology of the Cell
Verified
Journal Article
Open access
ASAkira C. Saito
Akira C. Saito
THTomohito Higashi
Tomohito Higashi
YFYugo Fukazawa
Yugo Fukazawa
TOTetsuhisa Otani
Tetsuhisa Otani
MTMasashi Tauchi
Masashi Tauchi
Hideki ChibaHideki Chiba
Hideki Chiba
Tight junctions (TJs) are composed of claudin-based TJ strands. The complexity of TJ strands regulates paracellular permeability of epithelial cells. Occludin and tricellulin contribute to the formation of the complex TJ-strand network possibly by connecting TJ strands and establishment of a tight barrier.

13 February 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MTMizuko Tanaka
Mizuko Tanaka
NINaoki Ichikawa-Tomikawa
Naoki Ichikawa-Tomikawa
NSNamiko Shishito
Namiko Shishito
KNKeisuke Nishiura
Keisuke Nishiura
TMTomiko Miura
Tomiko Miura
TSTakashi Sugino
Takashi Sugino
S100 family proteins have recently been identified as biomarkers in various cancers. Of this protein family, S100A14 and S100A16 are also believed to play an important role in tumor progression. The aim of the present study was to clarify the clinical significance and functional role of these molecules in breast cancer. In a clinical study, an immunohistochemical analysis of S100A14 and S100A16 expression in archival specimens of primary tumors of 167 breast cancer patients was performed. The relationship of S100A14 and S100A16 expression to patient survival and clinicopathological variables was statistically analyzed. In an experimental study, the subcellular localization and function of these molecules was examined by using the human breast cancer cell lines MCF7 and SK-BR-3, both of which highly express S100A14 and S100A16 proteins. Cells transfected with expression vectors and siRNA for these genes were characterized using in vitro assays for cancer invasion and metastasis. Immunohistochemical analysis of 167 breast cancer cases showed strong cell membrane staining of S100A14 (53% of cases) and S100A16 (31% of cases) with a significant number of cases with co-expression (p < 0.001). Higher expression levels of these proteins were significantly associated with a younger age (<60 years), ER-negative status, HER2-positive status and a poorer prognosis. Co-expression of the two proteins showed more aggressive features with poorer prognosis. In the human breast cancer cell lines MCF7 and SK-BR-3, both proteins were colocalized on the cell membrane mainly at cell-cell attachment sites. Immunoprecipitation and immunofluorescence analyses demonstrated that the 100A14 protein can bind to actin localized on the cell membrane in a calcium-independent manner. A Boyden chamber assay showed that S100A14 and S100A16 knockdown substantially suppressed the invasive activity of both cell lines. Cell motility was also inhibited by S100A14 knockdown in a modified dual color wound-healing assay. To our knowledge, this is the first report showing the correlation of expression of S100A14, S100A16, and co-expression of these proteins with poor prognosis of breast cancer patients. In addition, our findings indicate that S100A14 and S100A16 can promote invasive activity of breast cancer cells via an interaction with cytoskeletal dynamics. S100A14 and S100A16 might be prognostic biomarkers and potential therapeutic targets for breast cancer.

8 June 2011 in The Prostate
Verified
Journal Article
Closed access
PDF file
TMToshihiro Maeda
Toshihiro Maeda
MMMasaki Murata
Masaki Murata
Hideki ChibaHideki Chiba
Hideki Chiba
ATAkira Takasawa
Akira Takasawa
STSatoshi Tanaka
Satoshi Tanaka
NSNorimasa Sawada
Norimasa Sawada

16 October 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
KNKeisuke Nishiura
Keisuke Nishiura
NINaoki Ichikawa-Tomikawa
Naoki Ichikawa-Tomikawa
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
YKYasuto Kunii
Yasuto Kunii
KKKorehito Kashiwagi
Korehito Kashiwagi
Hideki ChibaHideki Chiba
Hideki Chiba
Schizophrenia is thought to be caused by a combination of genetic and environmental factors; however, its pathogenesis remains largely unknown. Here, we focus on the endothelial tight-junction protein claudin-5 (CLDN5), because the CLDN5 gene is mapped to the schizophrenia-associated 22q11.2 deletion region, and a single nucleotide polymorphism in the CLDN5 locus is also linked to schizophrenia. We show, by RT-qPCR and immunohistochemistry, that the expressions of CLDN5 mRNA and protein are significantly increased and decreased, respectively, in the schizophrenic prefrontal cortex (PFC) compared with control PFC. These changes were not observed in the schizophrenic visual cortex (VC), and neither the density nor diameter of the CD34-positive microvessels was altered in the schizophrenic PFC or VC. Interestingly, protein kinase A (PKA) was activated in the microvascular and perivascular regions of the schizophrenic PFC, and the pPKA-positive microvascular endothelial cells occasionally exhibited focal loss of CLND5. Since we previously demonstrated that cAMP induced CLDN5 mRNA expression and size-selective loosening of the endothelial barrier in PKA-independent and -dependent manners, respectively, a similar mechanism could contribute to the discrepancy between mRNA and protein expression of CLDN5 in the schizophrenic PFC. Taken collectively, these findings provide novel insights into the pathophysiology of schizophrenia.

24 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MKMANABU KOJIMA
MANABU KOJIMA
Kotaro SugimotoKotaro Sugimoto
Kotaro Sugimoto
MTMizuko Tanaka
Mizuko Tanaka
YEYuta Endo
Yuta Endo
HKHitomi Kato
Hitomi Kato
Hideki ChibaHideki Chiba
Hideki Chiba
Background: Among the claudin (CLDN) family, CLDN6 exhibits aberrant expression in various cancers, but its biological relevance has not yet been established. We generated a monoclonal antibody (mAb) against human CLDN6 and verified its specificity. By immunohistochemical staining and semi-quantification, we evaluated the relationship between CLDN6 expression and clinicopathological parameters in tissues from 173 cases of endometrial cancer. Results: The established mAb selectively recognized CLDN6 protein. Ten of the 173 cases (5.8%) showed high CLDN6 expression (score 3+), whereas 19 (11.0%), 18 (10.4%) and 126 (72.4%) cases revealed low CLDN6 expression (score 2+, 1+ and 0, respectively). In addition, intratumor heterogeneity of CLDN6 expression was observed even in the cases with high CLDN6 expression. The 5-year survival rates in the high and low CLDN6 groups was approximately 30% and 90%, respectively. Among the clinicopathological factors, the high CLDN6 expression was significantly associated with surgical stage III/IV, histological type, histological grade 3, lymphovascular space involvement, lymph node metastasis and distant metastasis. Furthermore, the high CLDN6 expression was an independent prognostic marker for overall survival of endometrial cancer patients (hazard ratio 3.50, p = 0.014). Conclusions: It can be concluded that aberrant CLDN6 expression is useful to predict poor outcome for endometrial cancer and might be a promising therapeutic target.

18 November 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KSKotaro Sugimoto
Kotaro Sugimoto
NINaoki Ichikawa-Tomikawa
Naoki Ichikawa-Tomikawa
KKKorehito Kashiwagi
Korehito Kashiwagi
CEChihiro Endo
Chihiro Endo
STSatoshi Tanaka
Satoshi Tanaka
Hideki ChibaHideki Chiba
Hideki Chiba
Significance: Cell adhesion is indispensable for multicellular organisms to form cohesive sheets and to serve as tissues and organs. In addition to the adhesive activity, it exhibits the signaling ability to organize a variety of cellular processes. However, the mechanism by which the cell adhesion signaling influences the cellular events, especially on regulation of gene expression, remains obscure. We determine that the cell adhesion signaling originated from the tight-junction protein claudin-6, which targets members of the nuclear receptor superfamily, such as retinoic acid receptor γ and estrogen receptor α, thereby regulating expression of the respective target genes. This signaling provides insight into regulation of nuclear receptor activity by cell adhesion.